FDA's Overreach on Compounded Peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times The peptide problem: Hype is outrunning the evidence ProHealth Longevity BPC157 Claims Evaluated: Most Effective BPC157 Peptide Brand on the Market (2026) The Peptide Craze Ground Truths